Skip to content
NanoPass Technologies Ltd Logo
  • HOME
  • APPLICATIONS
    • AESTHETIC TREATMENTS
    • THERAPEUTIC
    • PIPELINE
  • PRODUCT PLATFORM
    • MICRONEEDLE DEVICE
    • MEMS TECHNOLOGY
    • INSTRUCTIONS FOR USE
  • NEWS
    • PRESS RELEASES
    • MEDIA COVERAGE
  • PUBLICATIONS & REVIEWS
  • ABOUT US
    • COMPANY
    • MANAGEMENT
    • BOD
    • OUR VISION
    • QUALITY
    • PARTNERS
  • Contact
Home » News & Press » Media Coverage » Nanopass to begin trials with a device that may improve COVID-19 vaccines

Nanopass to begin trials with a device that may improve COVID-19 vaccines

Adela Ance2022-03-13T09:43:08+00:00March 13th, 2022|

Related Posts

  • The intradermal patch to replace COVID-19 vaccine needles and syringes

    March 13th, 2022

  • NanoPass developed the smallest FDA-approved microneedle (TechTime)

    January 3rd, 2022

  • ננו-פאס פיתחה את המחט הרפואית הזעירה בעולם (TechTime)

    January 2nd, 2022
  • HOME
  • APPLICATIONS
  • PRODUCT PLATFORM
  • NEWS
  • PUBLICATIONS & REVIEWS
  • ABOUT US
  • CONTACT
© 2009 - NanoPass. Rev. 04

The webpage you are accessing, and its content is intended for healthcare professionals and researchers only.

Request MicronJetTM sample

Contact us
Page load link
This site uses cookies Provided that you have accepted the use of cookies, Nanopass will use the “cookies” to facilitate the use of this site. Cookies are bits of text that are placed on your computer’s hard drive when you visit certain websites. Nanopass will only use temporary Cookies for the purpose of displaying alerts and disclaimers required by law. please read our privacy policy OK
Go to Top